Clearmind Medicine CMND Cash Flow Statement (2022-2026)

NASDAQ CMND
$1.73 -0.15 (-7.98%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income (Quarter) 0.00B-0.00B-5329.57B0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B
Depreciation and Depletion (Quarter) 0.00B4.28B-4.28B0.00B0.00B0.00B0.00B377.00726.00269.000.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation (Quarter) 0.00B1,004.34B-1004.33B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Deferred Taxes (Quarter) 0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B
Gains from Investment Securities (Quarter) 0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B
Cash from Operations (Quarter) -0.00B-3518.60B3,518.60B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.00B12.33B-12.33B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF) (Quarter) 0.00B4.28B0.00B0.00B0.00B377.00726.00269.000.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables (Quarter) 0.00B82.85B-82.84B-0.00B0.00B-0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B
Change in Account Payables (Quarter) 0.00B181.62B-181.62B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B-0.00B
Change in Accured Expenses (Quarter) -0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B751.00
Other Working Capital Changes (Quarter) 0.00B101.76B-101.76B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B
Investing Activities
Change in Acquisitions & Divestments (Quarter) 455.49B-0.00B0.00B-0.00B-0.00B
Cash from Investing Activities (Quarter) -0.00B0.00B-0.00B0.00B-0.00B0.00B-0.00B
Financing Activities
Other financing activities (Quarter) 0.00B0.00B-0.00B-0.00B0.00B0.00B
Cash from Financing Activities (Quarter) 580.72B-580.72B0.01B0.00B-0.00B0.00B0.01B0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.01B0.00B
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 582.56B0.01B0.00B-0.00B0.00B-0.00B0.01B
Dividend Payments
Dividends Paid - Common (Quarter) 0.00B385.82B0.00B0.00B-0.00B0.01B-0.00B-0.00B0.01B-0.00B-0.00B0.01B0.00B
Additional items
Exchange Rate Effect (Quarter) -319.190.35B-0.36B-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B20.000.00B-861.000.00B-0.00B
Change in Cash (Quarter) -0.00B-2983.98B2,983.98B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B0.00B
Beginning Cash Balance (Quarter) 0.00B3,369.79B0.00B0.00B0.01B0.01B0.00B0.00B
Free Cash Flow (Quarter) -0.00B-3518.60B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Net Cash Flow (Quarter) -0.00B-2937.88B0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.01B0.00B